Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA

Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA

Intravenous (IV) tissue-type plasminogen activator (tPA) is the only approved noninvasive therapy for acute ischemic stroke (AIS). However, after tPA treatment, the outcome of patients with different subtypes of stroke according to their vascular risk factors remains to be elucidated. We aim to expl...

Full description

Bibliographic Details
Main Authors: Dong, Yi, Cao, Wenjie, Ren, Jinma, Nair, Deepak S., Parker, Sarah, Jahnel, Jan L., Swanson-Devlin, Teresa G., Beck, Judith M., Mathews, Maureen, McNeil, Clayton J., Upadhyaya, Manas, Gao, Yuan, Dong, Qiang, Wang, David Z.
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527733/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527733/

Similar Items